Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
124,152,367
-
Share change
-
-147,358
-
Total reported value
-
$3,436,416,158
-
Put/Call ratio
-
17%
-
Price per share
-
$27.68
-
Number of holders
-
196
-
Value change
-
+$2,487,658
-
Number of buys
-
108
-
Number of sells
-
71
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2019
As of 31 Dec 2019,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,152,367 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, GREAT POINT PARTNERS LLC, and STATE STREET CORP.
This page lists
196
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.